Convergence on the Constraints and Challenges in the Awareness, Prevention, Treatment and CONTROL OF TYPE 2 DIABETES and Diabetes-Related Conditions

Convergence on the Constraints and Challenges in the Awareness, Prevention, Treatment and CONTROL OF TYPE 2 DIABETES and Diabetes-Related Conditions

Dr Chrysanthus Chukwuma Sr

Contact

Convergence on the Constraints and Challenges in the Awareness, Prevention, Treatment and CONTROL OF TYPE 2 DIABETES and Diabetes-Related Conditions

Article Fingerprint

ReserarchID

O79YZ

AI TAKEAWAY

Connecting with the Eternal Ground

Abstract

The global epidemiology of type 2 diabetes over time regarding the biologic, cultural, demographic, therapeutic regimen and lifestyle changes are factors which have been described with particular focus on the aetiology, complications, natural history and risks pertaining to the disorder. Expansive data depict that type 2 diabetes incidence and prevalence increase rapidly to the detriment of pecuniary measures in health services and society. Recent decades have been encumbered with tumultuous and contentious polemics marked with conflicts in research findings and budget cuts in the awareness, prevention, treatment and control of the constraints and challenges regarding diabetes and related conditions, especially in LIMCs. Our health systems are faced with adverse policy expansiveness to unavoidable or threatened accelerating global needs in health and development as well as a realizable paradigm of performing more with less. Strategies in the prevention, treatment and control of type 2 diabetes and diabetes-related conditions aim to mitigate the risk of the development of diabetes and its complications.

References

58 Cites in Article

Reference Format

L Augustin,C Kendall,D Jenkins,W Willett,H Astrup,A Barclay (2015). Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quarterly Consortium (ICQC).
D Aune,B Ó Hartaigh,L Vatten (2015). Resting heart rate and the risk of type 2 diabetes: A systematic review and dose–response meta-analysis of cohort studies.
M Bashir,M Pathan,S Raza,J Ahmad,A Azad,O Ishtiaq (2012). Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan.
E Burns (2017). Type 2 diabetes symptoms -drinking alcohol could reduce disease risk.
John Buse,Barry Gumbiner,Nancy Mathias,Debra Nelson,Barbara Faja,Randall Whitcomb (1998). Troglitazone Use in Insulin-Treated Type 2 Diabetic Patients.
J Buse (1999). Overview of current therapeutic actions in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
M Catalan,Z Herreras,M Pinyol,A Sala-Vila,A Amor,E De Groot,R Gilabert,E Ros,E Ortega (2015). Prevalence by sex of preclinical carotid atherosclerosis in newly diagnosed type 2 diabetes.
Junlei Chang,Yiming Li,Yu Huang,Karen Lam,Ruby Hoo,Wing Wong,Kenneth Cheng,Yiqun Wang,Paul Vanhoutte,Aimin Xu (2010). Adiponectin Prevents Diabetic Premature Senescence of Endothelial Progenitor Cells and Promotes Endothelial Repair by Suppressing the p38 MAP Kinase/p16INK4A Signaling Pathway.
C Chukwuma Sr (2014). Comparison of Mild Cognitive Impairment Between the Older People with Diabetes Mellitus and without Diabetes Melitus.
C Chukwuma Sr (2017). Carbohydrate-lipid interactions in obesity and diabetes.
Chukwuma Sr,C (2017). Clinical, economic and healthcare constraints and challenges using insulin analogues in the treatment and control of diabetes in vulnerable populations.
C Chukwuma Sr (2017). Syndemics of chronic and acute diseases in vulnerable populations.
Miriam De Kleijn,Yvonne Van Der Schouw,Peter Wilson,Diederick Grobbee,Paul Jacques (2002). Dietary Intake of Phytoestrogens Is Associated with a Favorable Metabolic Cardiovascular Risk Profile in Postmenopausal U.S. Women: The Framingham Study.
V De Mello,J Lindström,J Eriksson,P Ilanne-Parikka,S Keinänen-Kiukaanniemi,J Pihlajamäki,J Tuomilehto,M Uusitupa (2015). Markers of cholesterol metabolism as biomarkers in predicting diabetes in the Finnish Diabetes Prevention Study.
K Dungan,A Desantis (2017). Do dipeptidyl peptidase-4 (DPP-4) inhibitors improve outcomes in people with type 2 diabetes mellitus?.
Ricardo Godinho,Cristina Mega,Edite Teixeira-De-Lemos,Eugénia Carvalho,Frederico Teixeira,Rosa Fernandes,Flávio Reis (2015). The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A “Me Too” or “the Special One” Antidiabetic Class?.
Alain Golay,Nadine Guillet-Dauphiné,Anton Fendel,Christian Juges,J Assal (1995). The insulin-sparing effect of metformin in insulin-treated diabetic patients.
Victoria Higgins,James Piercy,Adam Roughley,Gary Milligan,Andrea Leith,James Siddall,Mike Benford (2016). Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015.
T Kadowaki,T Yamauchi,N Kubota,K Hara,K Ueki,K Tobe (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
B Kappel,N Marx,M Federici (2015). Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials.
S Khan,R Hull,K Utzschneider (2007). Mechanisms linking obesity to insulin resistance and type 2 diabetes.
Johanna Lampe (2003). Isoflavonoid and Lignan Phytoestrogens as Dietary Biomarkers.
S Ley,O Hamdy,V Mohan,F Hu (2014). Prevention and management of type 2 diabetes: Dietary components and nutritional strategies.
Yu-Qian Li,Chang-Qing Sun,Lin-Lin Li,Ling Wang,Yi-Rui Guo,Ai-Guo You,Yuan-Lin Xi,Chong-Jian Wang (2014). Resting heart rate as a marker for identifying the risk of undiagnosed type 2 diabetes mellitus: a cross-sectional survey.
Xiaotian Liu,Yuqian Li,Linlin Li,Luning Zhang,Yongcheng Ren,Hao Zhou,Lingling Cui,Zhenxing Mao,Dongsheng Hu,Chongjian Wang (2016). Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study.
C Maadjhou,C Nganou-Gnindjio,N Azabji-Kenfack,M Kuate,L,M Bimbai,A,M Katte,J-C,N Sobngw,E (2017). The effect of optimizing glycemic control using insulin on the heart rate variability in type 2 diabetes mellitus patients.
P Marques-Vidal,P Vollenweider,G Waeber (2015). Alcohol consumption and incidence of type 2 diabetes. Results from the CoLaus study.
Christopher Mcintosh,Hans-Ulrich Demuth,J Pospisilik,Raymond Pederson (2005). Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?.
Mdedge (2004). Starting insulin in type 2 diabetes: Continue oral hypoglycemic agents?.
M Monami,I Iacomelli,E Mannuci (2010). Dipeptidyl peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials.
S Montilla,G Marchesini,A Sammarco,M Trotta,P Siviero,C Tomino (2014). Drug utilization, safety, and effectiveness of exenatride, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFF Anti-diabetics Monitoring Registry.
Ncd (2016). Author response: A century of trends in adult human height.
Masaki Nishimura,Yasuhiro Izumiya,Akiko Higuchi,Rei Shibata,Jianhua Qiu,Chiho Kudo,Hwa Shin,Michael Moskowitz,Noriyuki Ouchi (2008). Adiponectin Prevents Cerebral Ischemic Injury Through Endothelial Nitric Oxide Synthase–Dependent Mechanisms.
Abdulfatai Olokoba,Olusegun Obateru,Lateefat Olokoba (2012). Type 2 Diabetes Mellitus: A Review of Current Trends.
An Pan,Jianqin Sun,Yanqiu Chen,Xingwang Ye,Huaixing Li,Zhijie Yu,Yanfang Wang,Wenjia Gu,Xinyi Zhang,Xiafei Chen,Wendy Demark-Wahnefried,Yong Liu,Xu Lin (2007). Effects of a Flaxseed-Derived Lignan Supplement in Type 2 Diabetic Patients: A Randomized, Double-Blind, Cross-Over Trial.
B Richter,E Bandeira-Echtler,K Bergerhoff,C Lerch (2008). Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.
M Riddle (1996). combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.
Ian Rowland,Marian Faughnan,Leane Hoey,Kristiina Wähälä,Gary Williamson,Aedin Cassidy (2003). Bioavailability of phyto-oestrogens.
D Russell-Jones,M-A Gall,M Niemeyer,M Diamant,S Del Prato (2015). Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials.
G Sartore,R Seraglia,S Burlina,A Bolis,R Marin,E Manzato,E Ragazzi,P Traldi,A Lapolla (2015). High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction.
U Schwab,M Uusitupa (2015). Diet heart controversies -Quality of fat matters.
Rei Shibata,Noriyuki Ouchi,Masahiro Ito,Shinji Kihara,Ichiro Shiojima,David Pimentel,Masahiro Kumada,Kaori Sato,Stephan Schiekofer,Koji Ohashi,Tohru Funahashi,Wilson Colucci,Kenneth Walsh (2004). Adiponectin-mediated modulation of hypertrophic signals in the heart.
R Shibata,K Sato,D Pimental,Y Takemura,S Kihara,K Ohashi,T Funahashi (2005). Adiponectin protects against myocardial ischaemiareperfusion injury through AMPK-and COX-2dependent mechanisms.
Seema Singla,Kiranjeet Kaur,Gurdeep Kaur,Harbir Kaur,Jasbinder Kaur,Shivani Jaswal (2009). Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control.
I Sluijs,E Cadier,J Beulens,A Van Der,A Spijkerman,V Van Der Schouw (2015). Dietary intake of carotenoids and risk of type 2 diabetes.
S Stoimeni,T Karagiannis,A Katsoula,E Athanasiadou,K Kazakos,E Bekiari (2017). Once-weekly dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis.
Mohammad Talaei,A Pan (2015). Role of phytoestrogens in prevention and management of type 2 diabetes.
Véronique Thibault,Mathieu Bélanger,Emilie Leblanc,Lise Babin,Stuart Halpine,Beverly Greene,Michelina Mancuso (2016). Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysis.
Pragya Tiwari (2015). Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update.
(2016). FDA Drug Safety Communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain.
J Utumatwishima,N Baker,R Bingham,B Ricks,M Mabundo,L Galvan-Delacruz,M Onuzumike,Sacks,S Chung,A Sumner (2017). High allostatic load score identifies African migrants at increased risk for diabetes and cardiovascular diseases: the Africans in America study.
Jean Utumatwishima,Rafeal Baker,Brianna Bingham,David Sacks,Anne Sumner (2017). HbA1C and fasting glucose perform poorly as screening tests for diabetes in African immigrants: the Africans in America study.
Liisa Valsta,Annamari Kilkkinen,Witold Mazur,Tarja Nurmi,Anna-Maija Lampi,Marja-Leena Ovaskainen,Tommi Korhonen,Herman Adlercreutz,Pirjo Pietinen (2003). Phyto-oestrogen database of foods and average intake in Finland.
N Vibhuti (2016). Low HDL cholesterol (hypoalphalipoproteinemia) and management.
E Well,S Choukem,P Dehayem,M Katte,J-C,N Mbanya,J,C Sobngwi,E (2017). Short-term effects of liraglutide versus vildagliptin on insulin secretion and sensitivity in type 2 diabetes (Liravis study).
Who (2015). Global action plan for the prevention and control of noncommunicable diseases 2013-2020.
S Wu,I Hopper,M Skibo,H Krum (2014). Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: Meta-analysis of randomized clinical trials with 55141 participants.
X Zhang,X-O Shu,Y-B Xiang,G Yang,H Li,H Cai,Y-T Gao,W Zheng (2010). Resting heart rate and risk of type 2 diabetes in women.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr Chrysanthus Chukwuma Sr. 2018. \u201cConvergence on the Constraints and Challenges in the Awareness, Prevention, Treatment and CONTROL OF TYPE 2 DIABETES and Diabetes-Related Conditions\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 17 (GJMR Volume 17 Issue F3): .

More Citation Formats

Select Citation Style:

Download Citation

Download Article

GJMR Volume 17 Issue F3
Pg. 9- 16

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-F Classification: NLMC Code: WD 200

Submission ReceivedDecember 14, 2016
Peer Review Double Blind
Handling Editor
Accepted January 2, 2017
Published January 15, 2017

Version of record

v1.2

Issue date

January 18, 2018

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Score: 101

Country: Nigeria

Subject: Global Journal of Medical Research - F: Diseases

Authors: Dr Chrysanthus Chukwuma Sr (PhD/Dr. count: 0)

View Count (all-time): 201

Total Views (Real + Logic): 3141

Total Downloads (simulated): 1638

Publish Date: 2018 01, Thu

Monthly Totals (Real + Logic):

Month 1: 19 views
Month 2: 46 views
Month 3: 53 views
Month 4: 26 views
Month 5: 31 views
Month 6: 38 views
Month 7: 34 views
Month 8: 37 views
Month 9: 30 views
Month 10: 16 views
Month 11: 39 views
Month 12: 40 views
Month 13: 26 views
Month 14: 22 views
Month 15: 41 views
Month 16: 46 views
Month 17: 34 views
Month 18: 36 views
Month 19: 23 views
Month 20: 21 views
Month 21: 22 views
Month 22: 31 views
Month 23: 32 views
Month 24: 19 views
Month 25: 21 views
Month 26: 35 views
Month 27: 22 views
Month 28: 24 views
Month 29: 29 views
Month 30: 32 views
Month 31: 41 views
Month 32: 28 views
Month 33: 39 views
Month 34: 33 views
Month 35: 34 views
Month 36: 29 views
Month 37: 29 views
Month 38: 36 views
Month 39: 23 views
Month 40: 20 views
Month 41: 17 views
Month 42: 13 views
Month 43: 13 views
Month 44: 15 views
Month 45: 31 views
Month 46: 27 views
Month 47: 23 views
Month 48: 31 views
Month 49: 41 views
Month 50: 45 views
Month 51: 17 views
Month 52: 25 views
Month 53: 23 views
Month 54: 24 views
Month 55: 22 views
Month 56: 37 views
Month 57: 31 views
Month 58: 25 views
Month 59: 43 views
Month 60: 30 views
Month 61: 42 views
Month 62: 35 views
Month 63: 21 views
Month 64: 24 views
Month 65: 26 views
Month 66: 26 views
Month 67: 23 views
Month 68: 33 views
Month 69: 42 views
Month 70: 28 views
Month 71: 25 views
Month 72: 32 views
Month 73: 42 views
Month 74: 34 views
Month 75: 25 views
Month 76: 28 views
Month 77: 21 views
Month 78: 34 views
Month 79: 18 views
Month 80: 27 views
Month 81: 25 views
Month 82: 41 views
Month 83: 20 views
Month 84: 26 views
Month 85: 44 views
Month 86: 18 views
Month 87: 31 views
Month 88: 28 views
Month 89: 24 views
Month 90: 44 views
Month 91: 32 views
Month 92: 37 views
Month 93: 31 views
Month 94: 20 views
Month 95: 42 views
Month 96: 38 views
Month 97: 44 views
Month 98: 49 views
Month 99: 39 views

Total Views: 3141

Total Downloads: 1638

2026 Trends

Published Article

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]